Peptides for Muscle Growth: What the Evidence Really Shows

Search for peptides for muscle growth and you will find long lists of injectable compounds promising faster gains and quicker recovery. The research tells a more careful story. This guide separates the peptides with real human evidence for building muscle from those that are still experimental, explains how each group is supposed to work, and sets out the safety and regulatory facts that most lists leave out.

Quick answer: The peptides with the strongest human evidence for muscle growth are dietary ones: protein, including collagen peptides, taken alongside resistance training. The injectable research peptides most often promoted for muscle (growth hormone secretagogues, IGF-1 analogues, myostatin inhibitors, BPC-157 and TB-500) have little or no controlled human evidence for building muscle. None is FDA-approved for that purpose, and all of them are prohibited in sport.

How muscle growth works

Muscle grows when muscle protein synthesis outpaces muscle protein breakdown over weeks and months. The two main drivers are mechanical tension from resistance training and an adequate supply of amino acids from the diet. Leucine, an essential amino acid found in high amounts in dairy, meat and eggs, is a key signal for switching protein synthesis on. Hormones such as growth hormone, IGF-1 and testosterone influence the process, and that is the logic behind most of the peptides marketed for muscle growth: change the hormonal signal and you might change the result. Whether that works in healthy people, and at what cost, is the question the evidence has to answer.

Peptides with human evidence for muscle growth

Dietary protein and protein peptides

Every protein you eat is digested into peptides and amino acids, so whey, casein and other protein supplements are, in a sense, the most studied peptides for muscle growth. A 2018 meta-analysis in the British Journal of Sports Medicine pooled 49 randomized controlled trials with 1,863 participants. Protein supplementation during resistance training of at least six weeks increased gains in strength (2.49 kg more on a one-repetition maximum) and fat-free mass (0.30 kg more) compared with training alone. The benefit was larger in people with training experience, smaller with increasing age, and leveled off at a total protein intake of about 1.62 g per kilogram of body weight per day.

Collagen peptides

Collagen peptides are hydrolyzed collagen protein. In a 12-week randomized trial, 53 older men with sarcopenia did supervised resistance training three times a week and took either 15 g of collagen peptides or a placebo daily. The collagen group gained more fat-free mass (4.2 kg vs 2.9 kg) and more quadriceps strength than the placebo group. Collagen lacks tryptophan and is low in leucine, so it is not a complete protein, but this trial suggests it can still contribute alongside training. Our guide to collagen peptides covers the wider research.

Research peptides marketed for muscle growth

These are the compounds that appear on most "best peptides for muscle growth" lists. The table summarizes what each group targets and the state of the human evidence.

Growth hormone secretagogues

Growth hormone secretagogues make the pituitary gland release more of its own growth hormone. There are two families: analogues of growth hormone-releasing hormone (GHRH), such as CJC-1295 and sermorelin, and agonists of the ghrelin receptor, such as ipamorelin, GHRP-2 and GHRP-6. In a 2006 trial in healthy adults, a single injection of CJC-1295 raised average growth hormone levels two- to ten-fold for six days or more and IGF-1 levels 1.5- to three-fold for 9 to 11 days. Raising a hormone level is not the same as building muscle, though, and that trial did not measure muscle.

The closest thing to a long-term muscle study is a two-year randomized trial of MK-677 (ibutamoren), an oral, non-peptide ghrelin-receptor agonist, in 65 healthy adults aged 60 to 81. After a year, fat-free mass rose by 1.1 kg in the MK-677 group and fell by 0.5 kg with placebo, but the extra lean mass did not translate into better strength or function. Fasting blood glucose rose and insulin sensitivity fell. We explain how these compounds work in more detail in our guide to HGH peptides.

IGF-1 analogues

IGF-1 (insulin-like growth factor 1) is the hormone that carries out much of growth hormone's effect on tissue. Modified versions such as IGF-1 LR3 were engineered for laboratory work because they bind less to the proteins that normally carry IGF-1 in the blood, so they stay active longer in cell culture. Recombinant IGF-1 (mecasermin) is approved only for children with severe primary IGF-1 deficiency, and low blood sugar is one of its known effects. We are not aware of any published controlled trials of IGF-1 LR3 or mechano growth factor (MGF) in healthy adults.

Myostatin inhibitors and follistatin

Myostatin is a protein that limits how large muscles can grow, and animals born without it develop unusually large muscles. That makes blocking myostatin an attractive research target, especially for muscle-wasting diseases. Follistatin, a natural protein that binds myostatin, is studied mainly in animal and gene-therapy research. The clearest human data comes from ACE-031, a drug designed to block myostatin signaling. A randomized trial in boys with Duchenne muscular dystrophy showed a trend toward more lean mass but was stopped early because of potential safety concerns, nosebleeds and small dilated blood vessels in the skin (telangiectasias).

BPC-157 and TB-500

BPC-157 and TB-500 are usually promoted for recovery rather than growth. Most of the published research on them is in animals and cells. The FDA states in its list of bulk drug substances that may present significant safety risks that it has identified no, or only limited, safety information for BPC-157 for the proposed routes of administration, and no human exposure data for the TB-500 fragment of thymosin beta-4.

Safety and regulation

Three facts apply to almost every research peptide marketed for muscle growth:

1. No FDA approval for muscle growth. None of these compounds is approved for building muscle in healthy people.
2. FDA safety concerns. The FDA has placed ipamorelin, GHRP-2, GHRP-6 and ibutamoren (MK-677) in category 2 of its compounding policy, meaning they may present significant safety risks. It cites possible immune reactions for several peptides, reports of serious adverse events with GHRP-2, a potential effect on cortisol and blood glucose with GHRP-6, and a potential for congestive heart failure in certain patients with ibutamoren. It also lists serious adverse events, including increased heart rate, associated with CJC-1295.
3. Banned in sport. The World Anti-Doping Agency Prohibited List for 2026 prohibits growth hormone-releasing factors and secretagogues (including CJC-1295, sermorelin, tesamorelin, ipamorelin, hexarelin, GHRP-2, GHRP-6 and MK-677), IGF-1 and its analogues, mechano growth factors, thymosin beta-4 and TB-500, myostatin inhibitors such as follistatin, and activin receptor blockers such as ACE-031 at all times. BPC-157 is prohibited under WADA's category of non-approved substances.

Quality is a separate issue. Peptides sold outside regulated pharmaceutical channels are not checked by any regulator, so their identity and purity depend entirely on the supplier's testing. Roids & Peps lists several of the compounds above, including those in our cellular growth signaling and recovery research areas, strictly as laboratory research materials: they are not sold for human use, and no dosing information is provided. Batch certificates of analysis are published in our COA library, and our testing process explains what each test shows.

What actually builds muscle

For people rather than laboratory models, the evidence points to well-understood basics:

• Progressive resistance training: gradually increasing load or volume over time is the main stimulus for growth.
• Enough protein: the meta-analysis above found gains leveled off at about 1.6 g per kilogram of body weight per day, spread across meals.
• Enough energy: building tissue is harder in a large calorie deficit.
• Sleep and recovery: the largest daily pulse of growth hormone comes during deep sleep, and recovery between sessions supports adaptation.
• Medical advice for medical problems: muscle loss from illness, aging or hormone deficiency should be assessed by a doctor, who can discuss approved treatments.

Frequently asked questions

What are the best peptides for muscle growth?

The peptides with the best human evidence are dietary protein and collagen peptides combined with resistance training. Injectable research peptides marketed for muscle growth lack controlled human evidence of benefit and are not approved for that use.

Do growth hormone peptides build muscle?

They raise growth hormone and IGF-1 levels, but that has not been shown to build meaningful muscle in healthy adults. In a year-long trial, MK-677 increased fat-free mass by about 1 kg without improving strength or function.

Is BPC-157 good for muscle growth?

There are no controlled human trials showing that BPC-157 builds muscle. Most of the research is in animals, the FDA reports limited safety data, and WADA prohibits it.

Are peptides for muscle growth legal?

Research peptides are sold for laboratory research, but they are not approved medicines for building muscle, and they are prohibited for athletes under the WADA code at all times.

Is collagen good for building muscle?

One randomized trial in older men found that collagen peptides plus resistance training produced more fat-free mass and strength than training with a placebo. Collagen is an incomplete protein, so it works best alongside other protein sources.

Sources

• Morton RW, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018.
• Zdzieblik D, et al. Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men. Br J Nutr. 2015.
• Teichman SL, et al. Prolonged stimulation of growth hormone and IGF-I secretion by CJC-1295 in healthy adults. J Clin Endocrinol Metab. 2006.
• Nass R, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults. Ann Intern Med. 2008.
• Campbell C, et al. Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy. Muscle Nerve. 2017.
• U.S. Food and Drug Administration: Certain bulk drug substances for use in compounding that may present significant safety risks
• World Anti-Doping Agency: Prohibited List